Related references
Note: Only part of the references are listed.Association of rs11801299 and rs1380576 polymorphisms at MDM4 with risk, clinicopathological features and prognosis in patients with retinoblastoma
Fenghua Yu et al.
CANCER EPIDEMIOLOGY (2019)
The RNase PARN Controls the Levels of Specific miRNAs that Contribute to p53 Regulation
Siddharth Shukla et al.
MOLECULAR CELL (2019)
Genetic analyses of aplastic anemia and idiopathic pulmonary fibrosis patients with short telomeres, possible implication of DNA-repair genes
Elena G. Arias-Salgado et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Elevated telomere dysfunction in cells containing the African-centric Pro47Ser cancer-risk variant of TP53
Stephen Tutton et al.
Oncotarget (2019)
Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up
Blanche P. Alter et al.
HAEMATOLOGICA (2018)
Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up
Blanche P. Alter et al.
HAEMATOLOGICA (2018)
Beyond the triad: Inheritance, mucocutaneous phenotype, and mortality in a cohort of patients with dyskeratosis congenita
Suzanne C. Ward et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
PARN and TOE1 Constitute a 3 ' End Maturation Module for Nuclear Non-coding RNAs
Ahyeon Son et al.
CELL REPORTS (2018)
The PHD finger protein Spp1 has distinct functions in the Set1 and the meiotic DSB formation complexes
Celine Adam et al.
PLOS GENETICS (2018)
The Guardian of the Genome Revisited: p53 Downregulates Genes Required for Telomere Maintenance, DNA Repair, and Centromere Structure
Eleonore Toufektchan et al.
CANCERS (2018)
De Novo Mutations Activating Germline TP53 in an Inherited Bone-Marrow-Failure Syndrome
Tsutomu Toki et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Essential role for centromeric factors following p53 loss and oncogenic transformation
Dan Filipescu et al.
GENES & DEVELOPMENT (2017)
Dysfunction of the MDM2/p53 axis is linked to premature aging
Davor Lessel et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Anatomy of Mdm2 and Mdm4 in evolution
Ban Xiong Tan et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2017)
TP53 Arg72Pro, mortality after cancer, and all-cause mortality in 105,200 individuals
Jakob B. Kodal et al.
SCIENTIFIC REPORTS (2017)
Meta-analytic support vector machine for integrating multiple omics data
SungHwan Kim et al.
BIODATA MINING (2017)
Subtelomeric p53 binding prevents accumulation of DNA damage at human telomeres
Stephen Tutton et al.
EMBO JOURNAL (2016)
Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth
Michael Dewaele et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants
Nilah M. Ioannidis et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
p53: A two-faced regulator of telomere metabolism?
Franck Toledo
BIOESSAYS (2016)
Postnatal telomere dysfunction induces cardiomyocyte cell-cycle arrest through p21 activation
Esther Aix et al.
JOURNAL OF CELL BIOLOGY (2016)
Posttranscriptional manipulation of TERC reverses molecular hallmarks of telomere disease
Baris Boyraz et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al.
NATURE (2016)
p53 downregulates the Fanconi anaemia DNA repair pathway
Sara Jaber et al.
NATURE COMMUNICATIONS (2016)
Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita
Hemanth Tummala et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Poly(A)-specific ribonuclease (PARN) mediates 3′-end maturation of the telomerase RNA component
Diane H. Moon et al.
NATURE GENETICS (2015)
Mice engineered for an obligatory Mdm4 exon skipping express higher levels of the Mdm4-S isoform but exhibit increased p53 activity
B. Bardot et al.
ONCOGENE (2015)
Age at cancer onset in germline TP53 mutation carriers: association with polymorphisms in predicted G-quadruplex structures
Charlotte Sagne et al.
CARCINOGENESIS (2014)
Guilty as CHARGED: p53's expanding role in disease
Jeanine L. Van Nostrand et al.
CELL CYCLE (2014)
Identification of TERRA locus unveils a telomere protection role through association to nearly all chromosomes
Isabel Lopez de Silanes et al.
NATURE COMMUNICATIONS (2014)
Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita
Bari J. Ballew et al.
HUMAN GENETICS (2013)
Positive and negative feedback loops in the p53 and mRNA 3′ processing pathways
Emral Devany et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Mutant Mice Lacking the p53 C-Terminal Domain Model Telomere Syndromes
Iva Simeonova et al.
CELL REPORTS (2013)
The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in Caucasians
Stian Knappskog et al.
CANCER CELL (2011)
An Illegitimate microRNA Target Site within the 3′ UTR of MDM4 Affects Ovarian Cancer Progression and Chemosensitivity
Jessika Wynendaele et al.
CANCER RESEARCH (2010)
Deconstructing nucleotide binding activity of the Mdm2 RING domain
Christina Priest et al.
NUCLEIC ACIDS RESEARCH (2010)
Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans
K. Linke et al.
CELL DEATH AND DIFFERENTIATION (2008)
Engineered telomere degradation models dyskeratosis congenita
Dirk Hockemeyer et al.
GENES & DEVELOPMENT (2008)
Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita
Blanche P. Alter et al.
BLOOD (2007)
MDMX overexpression prevents p53 activation by the MDM2 inhibitor nutlin
Baoli Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Hdmx modulates the outcome of P53 activation in human tumor cells
Mark Wade et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Inactivation of the p53 pathway in retinoblastoma
Nikia A. Laurie et al.
NATURE (2006)
Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4
J-C Marine et al.
CELL DEATH AND DIFFERENTIATION (2006)
A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network
F Toledo et al.
CANCER CELL (2006)
Flow cytometry and FISH to measure the average length of telomeres (flow FISH)
Gabriela M. Baerlocher et al.
NATURE PROTOCOLS (2006)
The codon 47 polymorphism in p53 is functionally significant
XX Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
GL Bond et al.
CELL (2004)
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
MC Marin et al.
NATURE GENETICS (2000)
Share Paper
